New therapeutic avenues in ulcerative colitis: Thinking out of the box

Joana Torres, Silvio Danese, Jean Frédéric Colombel

Research output: Contribution to journalArticlepeer-review


Ulcerative colitis (UC) is a chronic idiopathic inflammatory disease of the gastrointestinal tract that affects the mucosal lining of the colon. Recent epidemiological data show that its incidence and prevalence are increasing in many parts of the world, in parallel with altered lifestyles, improved access to health, improved sanitation and industrialisation rates. Current therapeutic strategies for treating UC have only been moderately successful. Despite major recent advances in inflammatory bowel disease therapeutic resources, a considerable proportion of patients are still refractory to conventional treatment. Less than half of all patients achieve long-term remission, many require colectomy, and the disease still has a major impact on patients' lives. Moreover, recent data point to slightly raised mortality. While these outcomes could be partly improved by optimising current therapeutic strategies, they clearly highlight the need to develop new therapies. Currently, a number of promising and innovative therapeutic approaches are being explored, some of which will hopefully survive to reach the clinic. Until such a time arrives, it is important that a better understanding of the clinical particularities of the disease, an improved knowledge of the host-microbiome negative interactions and of the environmental factors beyond disease development is achieved to obtain the final and desired outcome: to provide better treatment and quality of life for patients with this disabling disease.

Original languageEnglish
Pages (from-to)1642-1652
Number of pages11
Issue number11
Publication statusPublished - Nov 2013

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'New therapeutic avenues in ulcerative colitis: Thinking out of the box'. Together they form a unique fingerprint.

Cite this